Reach for the benefits of Enablex

Long-term efficacy data. Demonstrated severity data. No QT prolongation precaution in the label. No significant difference in memory compared with placebo in healthy volunteers.

When your OAB patients ask about the water balloon, they may be asking about Enablex.

Brand name: Enablex
Generic name/category: darifenacin, muscarinic receptor antagonist
Company: Novartis
Country/Market: USA, North America
Indication(s)/use: overactive bladder (OAB)
Target: Healthcare Professionals (HCP)
Tagline: Bladder effective and M3 selective
Publication: Urology Times June 2009

To see all of the ads from this campaign, click here
To see all of this brand’s ads, click here